L10.5

Drug-induced pemphigus

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

RxHCC V08

RXHCC314

Pemphigus, Pemphigoid, and Other Bullous Skin Disorders

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · L10.5
Use additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Inherited from L10Pemphigus
Excludes 1

pemphigus neonatorum (L01.03)

Inherited from L10-L14Bullous disorders
Excludes 1

benign familial pemphigus [Hailey-Hailey] (Q82.8) staphylococcal scalded skin syndrome (L00) toxic epidermal necrolysis [Lyell] (L51.2)

Inherited from chapter 12Diseases of the skin and subcutaneous tissue
Excludes 2

certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) lipomelanotic reticulosis (I89.8) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) systemic connective tissue disorders (M30-M36) viral warts (B07.-)

Official Guidelines for L10.5

FY 2026 ›
I.C.12Chapter-specific guidanceChapter 12: Diseases of the Skin and Subcutaneous Tissue

Subsections

Find L10.5 in the alphabetic index

1 index path leads to this code